Shuo Y. Chen

Guangzhou Key Laboratory Of Targeted Therapy For Gynecologic Oncology, Guangdong Provincial Key Laboratory Of Major Obstetric Diseases
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Polystyrene nanoparticles promote endometrial cancer development through the ACSS2-mediated reprogramming of arachidonic acid metabolism.

Polystyrene nanoparticles promote endometrial cancer development through the ACSS2-mediated reprogramming of arachidonic acid metabolism.

Journal: Cell death discovery

Published: October 29, 2025

A Tumor-Targeted tRF Therapeutics Triggers Ovarian Cancer Ferroptosis via Dual Inhibition of System Xc.

A Tumor-Targeted tRF Therapeutics Triggers Ovarian Cancer Ferroptosis via Dual Inhibition of System Xc.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: October 24, 2025

A causal glycerophospholipid-IL-18R1-CD9 axis connects lipid metabolism and T-cell activation in atopic dermatitis.

A causal glycerophospholipid-IL-18R1-CD9 axis connects lipid metabolism and T-cell activation in atopic dermatitis.

Journal: Briefings in bioinformatics

Published: October 03, 2025

piR-26681 suppresses ovarian cancer progression by enhancing METTL3/METTL14-mediated m6A modification of FBXO16 and impairing DNA repair via MORF4L1 degradation.

piR-26681 suppresses ovarian cancer progression by enhancing METTL3/METTL14-mediated m6A modification of FBXO16 and impairing DNA repair via MORF4L1 degradation.

Journal: Cellular & molecular biology letters

Published: July 31, 2025

SNORD9 promotes ovarian cancer tumorigenesis via METTL3/IGF2BP2-mediated NFYA m6A modification and is a potential target for antisense oligonucleotide therapy.

SNORD9 promotes ovarian cancer tumorigenesis via METTL3/IGF2BP2-mediated NFYA m6A modification and is a potential target for antisense oligonucleotide therapy.

Journal: Life sciences

Published: November 25, 2024

Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer.

Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer.

Journal: Molecular cancer

Published: September 24, 2024

piR-26441 inhibits mitochondrial oxidative phosphorylation and tumorigenesis in ovarian cancer through m6A modification by interacting with YTHDC1.

piR-26441 inhibits mitochondrial oxidative phosphorylation and tumorigenesis in ovarian cancer through m6A modification by interacting with YTHDC1.

Journal: Cell death & disease

Published: September 03, 2024

Causal relationship between 91 circulating inflammatory proteins and gynecological diseases: A two-sample bidirectional Mendelian randomization study.

Causal relationship between 91 circulating inflammatory proteins and gynecological diseases: A two-sample bidirectional Mendelian randomization study.

Journal: International journal of biological macromolecules

Published: September 03, 2024

piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer.

piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer.

Journal: NPJ precision oncology

Published: January 16, 2024

SNORD3B-2 promotes endometrial carcinoma progression by 2'-O-methylation modification of PLK1 and regulating RAB17 alternative splice.

SNORD3B-2 promotes endometrial carcinoma progression by 2'-O-methylation modification of PLK1 and regulating RAB17 alternative splice.

Journal: Genes & diseases

Published: November 11, 2023

SNORD99 promotes endometrial cancer development by inhibiting GSDMD-mediated pyroptosis through 2'-O-methylation modification.

SNORD99 promotes endometrial cancer development by inhibiting GSDMD-mediated pyroptosis through 2'-O-methylation modification.

Journal: Journal of cellular and molecular medicine

Published: October 20, 2023

Characterization of hypoxia-responsive states in ovarian cancer to identify hot tumors and aid adjuvant therapy.

Characterization of hypoxia-responsive states in ovarian cancer to identify hot tumors and aid adjuvant therapy.

Journal: Discover oncology

Published: September 29, 2023

Showing 1-12 of 72

Last Updated: 09/26/2026